1. 518 Phase 1B trial of monalizumab (NKG2A inhibitor) plus durvalumab: safety and efficacy in patients with metastatic ovarian, cervical, and microsatellite-stable endometrial cancers. (4th December 2020) Authors: Banerjee, Susana; Oaknin, Ana; Sanchez-Simon, Inmaculada; Salgado, Alfonso Cortes; Patel, Sandip Pravin; Oza, Amit; Das, Mayukh; Kourtesis, Panagiotis; Ascierto, Maria Libera; Diamond, Jennifer R Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗